Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options 
CureVac Streamlines European Network for mRNA Product Manufacturing
CureVac right-sizes manufacturing network to adapt to changes in vaccine peak demandsDemand reassessed for first-generation COVID-19 vaccine candidate, CVnCoV, currently...
Tactoset® Injectable Bone Substitute Now FDA Cleared for Hardware Augmentation
510(k) clearance expands the capability of Tactoset for augmenting suture anchor fixationBEDFORD, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Anika...
Digital Mental Healthcare Provider Ahead Launches New Medication Management Service and Expands Provider Network
Affordable new subscription offering for ADHD treatment meets high consumer demandSAN FRANCISCO, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Ahead, the...
Optimi Health Updates Build-Out of Mushroom Production and Research Facility
OPTIMI Health Facility Construction Fig 1 Fig 1 Building 261 NE view OPTIMI Health Facility Construction Fig 2 Fig 2...
Scopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Appointments of John Rossi, Ph.D. and Nagy Habib, Ch.M., F.R.C.S. to the Scientific Advisory Board
Dr. Rossi is a world leader in the development of RNA interference, the Lidow Family Research Endowed Chair and Professor...
Skye Bioscience Announces Special Virtual Investor Presentation
Skye Bioscience Investor Hour Please join us for a special investor presentation. SAN DIEGO, CA, Sept. 14, 2021 (GLOBE NEWSWIRE)...
CampDoc Becomes a Daxko Certified Partner with Seamless Integration for YMCAs and JCCs
ANN ARBOR, Mich., Sept. 14, 2021 (GLOBE NEWSWIRE) -- CampDoc, the leading Electronic Health Record (EHR) system for camps, has...
Nkarta to Participate at Upcoming Investor Conference
SOUTH SAN FRANCISCO, Calif., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural...
Published Study Shows Healthy Extracts Breakthrough Nutraceutical Formulation, ACTIVATE, Naturally Enhances Key Brain Activity by 46%
UBN ACTIVATE™ UBN ACTIVATE™ is clinically proven to enhance brain function, improve cognition, memory, focus, and mood while supporting natural...
Acasti Pharma to Present at the Oppenheimer Fall Healthcare Summit on September 21ˢᵗ
LAVAL, Québec, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST),...
SELLAS Life Sciences to Present at the 2021 Cantor Virtual Global Healthcare Conference on September 28th
NEW YORK, Sept. 14, 2021 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ("SELLAS" or the “Company”), a...
Daxor Corporation Presents New Data Validating the Benefit of the BVA-100® Blood Test for Heart Failure Patients at Key Scientific Society Meeting
Data from Three New Studies and Two Ongoing Trials Presented at the Heart Failure Society of America Annual Scientific Meeting...
Sarepta Therapeutics to Showcase Data from its Gene Therapy and RNA Platforms at World Muscle Society 2021 Virtual Congress
CAMBRIDGE, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare...
Vallon Pharmaceuticals Announces Formation of Scientific Advisory Board
- Inaugural appointments include globally renowned leaders and experts on attention-deficit/hyperactivity disorder (ADHD) and stimulant abuse PHILADELPHIA, PA, Sept. 14,...
Treatment.com International Inc. Obtains DTC Eligibility for its Common Shares in the U.S.
VANCOUVER, British Columbia, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Treatment.com International Inc. (“Treatment or the “Company”) (CSE: TRUE) (OTC: TREIF)...
electroCore Announces 510(k) Clearance of gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) to Treat Paroxysmal Hemicrania and Hemicrania Continua
ROCKAWAY, NJ, Sept. 14, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that...
Perception Neuroscience initiates Phase 2a study of PCN-101 (R-ketamine) for treatment resistant depression
NEW YORK and BERLIN, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Perception Neuroscience (Perception), an atai Life Sciences (atai) biopharmaceutical company...
LeaderMed Group and OPKO Health Form Joint Venture to Develop and Commercialize Oxyntomodulin and Factor VIIa-CTP in China and Other Asian Territories
SHANGHAI and MIAMI, Sept. 14, 2021 (GLOBE NEWSWIRE) -- LeaderMed Health Group Limited, a pharmaceutical development company with operations based...
Pyxis Oncology Appoints Jay M. Feingold, M.D., Ph.D., as Chief Medical Officer
Industry veteran strengthens Pyxis team with expertise in clinical development, medical affairs and antibody-drug conjugates (ADCs)CAMBRIDGE, Mass., Sept. 14, 2021...
Emergent BioSolutions Secures Multi-Year Development and Manufacturing Agreement with Providence Therapeutics for its mRNA COVID-19 Vaccine Candidate, PTX-COVID19-B
Total baseline value for Emergent is approximately $90 million USD, further expanding the collaboration between the companies, which began in...